Blood-Sparing Efficacy of Oral Tranexamic Acid in Primary Total Hip Arthroplasty

详细信息    查看全文

• 作者：Qunn Jid Lee ; MBChB ; FRCSEd (Ortho) ; FHKAM (Ortho) ; Wai Yee Esther Chang ; BHS (Nursing) ; Yiu Chung Wong ; MBBS ; FRCS ; FHKAM (Ortho)
• 关键词：oral tranexamic acid ; total hip arthroplasty ; total blood loss ; hidden blood loss ; hemoglobin drop
• 刊名：The Journal of Arthroplasty
• 出版年：2017
• 出版时间：January 2017
• 年：2017
• 卷：32
• 期：1
• 页码：139-142
• 全文大小：203 K
• 卷排序：32

文摘

Tranexamic acid (TXA) has been shown to be effective in reducing blood loss, hemoglobin drop, and blood transfusion in primary total hip arthroplasty. Most studies used intravenous form or topical form. This study was to assess the blood-sparing efficacy and safety of oral TXA in total hip arthroplasty.MethodsPatients with primary total hip arthroplasty from 2012 to 2015 were recruited. Trial group with 1 gm of oral TXA 2 hours preoperatively, and 6 hours and 12 hours postoperatively was compared with the control group without drug. Outcome measures were intraoperative blood loss, drain output, observed total blood loss, actual total blood loss, hidden blood loss, hemoglobin drop, blood transfusion requirement, thromboembolic complications, cerebrovascular or cardiovascular complications, and mortality.ResultsAfter exclusion, 108 patients were included—54 in trial group and 54 in control group. There was no significant difference in the baseline characteristics. The trial group had significantly higher postoperative hemoglobin (10.3 vs 9.4 g/dL), lower hemoglobin drop (3.0 vs 4.1 g/dL), lower hidden blood loss (149 vs 354 mL), and lower actual total blood loss (847 vs 1096 mL). There was no significant difference in thromboembolic complications or mortality. There was also no periprosthetic infection or drug allergy.ConclusionOral TXA is effective in blood sparing in terms of reduction in hemoglobin drop, hidden blood loss, and actual total blood loss. It is safe and is an alternative to the intravenous or topical form.